Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. - Wikidata - awgldk - TriplyDB

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

http://www.wikidata.org/entity/Q37668231

about

The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic Phenotypes The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis The role of EMT and MET in cancer dissemination Glioblastoma Circulating Cells: Reality, Trap or Illusion?MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis Live imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transition Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer Epithelial-mesenchymal transition: An emerging target in tissue fibrosis The cancer stem cell niche--there goes the neighborhood?Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis 14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance ASAP3 upregulation contributes to colorectal carcinogenesis and indicates poor survival outcome Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition Rho activation is apically restricted by Arhgap1 in neural crest cells and drives epithelial-to-mesenchymal transition.Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective.Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways Epilog: Cajal's unique and legitimated school.EMT and inflammation: inseparable actors of cancer progression.Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression.TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment Gadd45 proteins: relevance to aging, longevity and age-related pathologies.EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts.LOXL2 in epithelial cell plasticity and tumor progression.Multilayer control of the EMT master regulators.Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models.Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).

P2860

Q24617121-0728F5A8-1DBA-47C7-BCA2-975D5F0C693B Q24633875-817777A2-F766-4D61-9659-D1BC95BE2598 Q26752391-CB995893-F4E4-4018-B75E-91F7B543C6C3 Q26783022-15761601-9C6F-4D40-8F17-AD5343AED751 Q26796298-2063D8A6-2594-4AF3-A5B2-2A82FEA2D131 Q26823823-5098FFF7-B87F-4DD4-A4F5-5B38D0BE0D92 Q26851458-B4F02D3A-B0CB-4A2B-8399-584FE270BEDB Q27025321-9A834910-70B2-44FC-9E3F-96A07FD1A988 Q27310034-FFBDEB89-E2C3-45E9-AD9B-BA42B9F4459E Q27330504-C3BBE647-8F25-46A3-AD70-3C140A580168 Q28082679-61E3FD52-0BE3-476D-95B9-6897351ED73D Q28083351-16DB0D63-9378-4FA5-A787-98291E17E772 Q28244178-289682EE-F0DA-43E8-8E33-E4E404960491 Q28281068-237BDFF1-7CA3-4400-BB59-14EDEC81B1B2 Q28307191-95AEB059-E18D-479D-ADE7-97510C8A7823 Q28385396-3980524B-6664-476F-93BA-C28149C27A23 Q28538690-5E2099FE-07C5-4C1A-B131-968745DF79D8 Q30008732-379B8841-AC11-44C7-BB1E-2099F963E371 Q30415888-E4CF705C-C9EF-4CD5-8DAB-63DF8AC24954 Q30572435-0DD52C0C-1D81-4869-96C1-001C23C9C810 Q30853689-AF61939E-5A5A-484E-90D1-7E256A627AB0 Q33704284-CAD2F6A7-16B4-426D-9D4B-FF5C83454265 Q33776664-D76A95AE-9B1A-47D3-9D03-D85F64215922 Q33809320-1A7341DF-78EF-423C-A1B8-CE33A0335158 Q33835962-325CC6C1-1D23-4418-9EF0-0ED8AB176A87 Q33869755-E1873610-FCCE-4994-BAE8-3FC14EAF6C4B Q34048090-08DE2C45-62A8-4A3D-B342-9F0470B49F33 Q34100276-E8071621-8EA2-4CDA-884A-6B3D29800C71 Q34153199-2D1E97CD-0922-4B5F-94D4-CFEB399B6881 Q34222845-F684876F-A3B5-4DC0-B03B-0BA1732DFFB4 Q34288822-79C87462-73EB-48B8-B093-32680C88DECA Q34298918-9F464DC1-CF14-442C-855A-99351684FF53 Q34303455-B47AEDE5-EFE3-4C67-8145-B734693AFE63 Q34340552-60A1FBE6-16C7-4D93-8FC0-57F03B62830E Q34491426-25AC5FA5-E033-42BF-8397-E10110E6A309 Q34556186-B7B47D06-EFFF-4134-A8A8-05F9BDE6BAD2 Q34558918-F42D6DE4-A70E-4D5B-988F-2AF5B4CFAA46 Q34672166-5743CED0-7EAF-407F-9BBD-C34B0AC01A2A Q34781112-B7FCE48B-C780-4856-BE20-57B8F0EBA39B Q34782535-86485B05-D5F6-4247-8B91-F4354BB5CC90

P2860

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

http://www.wikidata.org/entity/Q37668231

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@en

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@nl

type

label

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@en

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@nl

prefLabel

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@en

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@nl

P1433

Q37668231-73EC81B2-F434-46D8-9C10-E231C815C96C

P1476

Q37668231-E5C0C233-1B3E-4600-AF62-C5CFF3160BE8

P2093

Q37668231-4450B6E4-7C00-48FE-97B9-047B1FF46FB1

Q37668231-637C4A75-717A-4682-B16E-384AE4ACA4C6

P2860

Q37668231-024BA607-7427-4087-B054-22794D7519CF

Q37668231-02F2F951-878B-4292-B4A5-3F83012D48D8

Q37668231-0643C28E-5896-4CDA-BD97-27313677235E

Q37668231-0694512B-48EF-425F-A230-A66A4B53E11C

Q37668231-0740FA6F-9F00-4736-A4A2-CE880A1C0FBD

Q37668231-07F31BB9-B108-40E3-AAD8-CE58C2BA543B

Q37668231-0AA2C60E-8D03-4214-9BC8-CD801C2543C7

Q37668231-0F18E548-9AE3-416D-8F60-BEC829BCDDE4

Q37668231-109A1924-D155-46DE-9329-0011F439F49A

Q37668231-13659977-8BC5-4DC6-AD22-85A8D2A152A6

P304

Q37668231-2A111A51-25F0-4BE5-9AEE-7320F3429131

P31

Q37668231-2FF02122-2687-481E-9BD7-B8818BC9F8DE

Q37668231-50EB8B94-8B2C-42CE-B78A-E92461CB57CB

P356

Q37668231-D5395C2A-B321-4F3F-93E1-CB230ECD4291

P433

Q37668231-A9B94A12-0B1A-4007-99D6-FF6A2870F2E5

P478

Q37668231-CBB62AAD-817F-47A9-9C95-694F626B5C04

P577

Q37668231-806FAEB7-6A1B-4DBF-83F0-C0A11D35593B

P5875

Q37668231-B3EF52EE-370E-4E40-9623-20E68E34F08F

P698

Q37668231-999B1994-E3E1-4402-AD2E-8742440F0395

P921

Q37668231-770443DA-E9DA-41FF-A76F-55C9495157B7

Q37668231-CE69B348-C497-4A38-8E40-8340F0A7F02E

P932

Q37668231-2046A000-A579-4CA7-83C4-41AD17DFFBFE

P356

P1433

EMBO Molecular Medicine

P1476

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.

@en

P2093

Jose Miguel López-Novoa

http://www.w3.org/2001/XMLSchema#string

M Angela Nieto

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

Epithelial-mesenchymal transition and its implications for fibrosis

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis

Direct regulation of TWIST by HIF-1alpha promotes metastasis

Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

The basics of epithelial-mesenchymal transition

Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

P304

303-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.200900043

http://www.w3.org/2001/XMLSchema#string

P433

6-7

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40848598

http://www.w3.org/2001/XMLSchema#string

P698

20049734

http://www.w3.org/2001/XMLSchema#string

P921

P932

3378143

http://www.w3.org/2001/XMLSchema#string